Eur. J. Haematol., Oct (2012)
High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Leuk. Lymphoma., Jan;54(1):202-4 (2013)
Myeloid sarcoma of the heart.
Leuk. Lymphoma., Dec;53(12):2511-4 (2012)
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
Blood., Apr;119(16):3705-11 (2012)
Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.
Blood., Jun;119(26):6198-208 (2012)
Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia.
Haematologica., May;97(5):739-42 (2012)
Cancer risk associated with long-term use of acetaminophen in the prospective VITamins and lifestyle (VITAL) study.
Cancer Epidemiol. Biomarkers Prev., Dec;20(12):2637-41 (2011)
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment.
J. Clin. Oncol., Nov;29(33):4417-23 (2011)
Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization.
PLoS ONE., 6(9):e24265 (2011)
Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study.
Cancer Epidemiol. Biomarkers Prev., Oct;20(10):2298-308 (2011)
Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study.
J. Clin. Oncol., Jun;29(17):2424-31 (2011)
Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.
Haematologica., Jun;96(6):914-7 (2011)
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.
J. Clin. Oncol., Mar;29(9):1190-7 (2011)
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.
Blood., Oct;116(14):2420-8 (2010)
Pretargeted radioimmunotherapy for hematologic and other malignancies.
Cancer Biother. Radiopharm., Apr;25(2):125-42 (2010)
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
J. Clin. Oncol., Jun;28(17):2831-8 (2010)
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study.
J. Clin. Oncol., Apr;28(10):1766-71 (2010)
The power of comparative studies.
Leuk. Res., May;33(5):610-2 (2009)
Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease.
Clin. Chem. Lab. Med., 46(5):648-54 (2008)
Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.
Blood., May;111(9):4813-6 (2008)